{"abstract": "Sanofi-Aventis sees a reasonable chance of buying U.S. biotech Genzyme at a fair price, but expects it will take some time to agree a deal that would further diversify the French drugmaker and strengthen its U.S. foothold, Reuters reported.", "web_url": "https://dealbook.nytimes.com/2010/09/16/sanofi-chief-reasonable-chance-of-genzyme-deal/", "snippet": "Sanofi-Aventis sees a reasonable chance of buying U.S. biotech Genzyme at a fair price, but expects it will take some time to agree a deal that would further diversify the French drugmaker and strengthen its U.S. foothold, Reuters reported.", "lead_paragraph": "Sanofi-Aventis sees a reasonable chance of buying American biotech Genzyme at a fair price, but expects it will take some time to agree a deal that would further diversify the French drug maker and strengthen its United States foothold, Reuters reported.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sanofi Chief: \u2018Reasonable\u2019 Chance of Genzyme Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Genzyme Corp", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Sanofi-Aventis SA", "rank": 2, "major": "N"}], "pub_date": "2010-09-16T09:51:51+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/b9d73789-0f71-5862-afca-5914f70fd478", "word_count": 217, "uri": "nyt://article/b9d73789-0f71-5862-afca-5914f70fd478"}